Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review
Patients with luminal breast cancer (BC) may develop central nervous system metastases in 20%–40% of cases. Radiation or surgical therapy represents the cornerstone of treating central nervous system metastases. Meanwhile, the best practice for metastatic luminal BC involves using cyclin-dependent k...
Saved in:
| Main Authors: | Maria Rosaria Valerio, Calogero Cipolla, Martina Greco, Chiara Mesi, Francesca Modica, Vittorio Gebbia, Giuseppa Scandurra, Daniela Sambataro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-03-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Online Access: | https://doi.org/10.1177/17588359251317847 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion
by: Calogero Cipolla, et al.
Published: (2024-11-01) -
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer
by: Maria Rosaria Valerio, et al.
Published: (2025-02-01) -
Abemaciclib and Letrozole in Metastatic Male Breast Cancer
by: Leon Schönfeld, et al.
Published: (2024-11-01) -
Menthol Toxicity: An Unusual Cause of Coma
by: Motaz Baibars, et al.
Published: (2012-01-01) -
Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study
by: Sara M. Tolaney, et al.
Published: (2025-03-01)